相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
沉重的后果:肥胖流行中的污染隐藏的重量:叙述性审查
Seda Nur Köktürk1, Hülya Yardımcı2
1Department of Nutrition and Dietetics, Ankara University Graduate School of Health Sciences, Ankara, Türkiye, Turkey. snkokturk@ankara.edu.tr.
Current obesity reports
|September 22, 2025
概括
环境污染与全球肥胖流行病有关. 暴露于空气和塑料等污染物会破坏新陈代谢并增加体重,特别是在弱势群体中.
科学领域:
- 环境健康 环境健康
- 代谢科学 代谢科学
- 流行病学 流行病学
背景情况:
- 全球肥胖流行是一个重大的公共卫生问题.
- 新出现的证据表明,环境因素在肥胖的发展中起着作用.
- 了解污染对代谢健康的影响对于预防至关重要.
研究的目的:
- 审查环境污染和肥胖之间的关系.
- 整合流行病学和生物证据,以污染物诱导的体重增加.
- 确定对弱势群体和代谢中断的影响.
主要方法:
- 流行病学研究的系统审查.
- 对污染物影响的机械学研究的分析.
- 人类测量和生物数据的综合.
主要成果:
- 各种污染物 (空气,噪音,光,POPs,微塑料) 与肥胖风险有关.
- 污染物破坏新陈代谢过程,激素平衡,并诱导炎症.
- 易受伤害的群体 (儿童,老年人) 面临着污染暴露的高风险.
结论:
- 环境污染是导致肥胖流行病的一个重要因素.
- 减轻污染暴露对代谢健康和预防肥胖至关重要.
- 需要进一步的研究和公共卫生政策来解决污染引起的代谢风险.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Stress Prevention and Stress Management Techniques IV
230
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
230
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248

